Savara Pharmaceuticals
SVRA
#6569
Rank
NZ$0.98 B
Marketcap
$5.76
Share price
0.62%
Change (1 day)
-24.14%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -$0.46

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.50. In 2022 the company made an earnings per share (EPS) of -$0.44 an increase over its 2021 EPS that were of -$0.60.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.463.62%
2022-$0.44-26.47%
2021-$0.60-59.52%
2020-$1.49-56.48%
2019-$3.422.66%
2018-$3.33-38.56%
2017-$5.42-71.06%
2016-$18.74-37.06%
2015-$29.784.35%
2014-$28.54-25.81%
2013-$38.46-8.82%
2012-$42.19-27.66%
2011-$58.32-58.41%
2010-$140.21-86%
2009-$1,0014.13%
2008-$961.6224%
2007-$775.50-35.9%
2006-$1,21095%
2005-$620.4053.85%
2004-$403.2644.44%
2003-$279.18-40%
2002-$465.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.77 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA